Fc-Modified IVIG with Enhanced Blood–Brain Barrier Penetration Ameliorates Cognitive Deficits and Neuropathology in A53T α-Synuclein Transgenic Mice

Related articles

1. FDA-Approved Passive Immunization Treatments Against Aβ in Alzheimer’s Disease: Where Are We Now?

   This article has 3 authors:

   1. Martin Higgins
   2. Veronica Wasef
   3. Andrea Kwakowsky

2. From Neurotoxicity to Neuroprotection: Photobiomodulation against the Effects of the SARS-CoV-2 Spike Protein in an Alzheimer's Disease Model

   This article has 6 authors:

   1. Erick José Nogueira Andrade
   2. Luiza de Andrade Giraldi
   3. Milena Yuki Rosental Sudo
   4. Lucas de Paula Ramos
   5. Geisa Rodrigues Salles
   6. Cristina Pacheco-Soares

3. Optimizing Fingolimod Dosing in STZ-Induced Cognitive Impairment: Divergent Behavioral and Histopathological Responses Reveal a Narrow Neuroprotective Window

   This article has 14 authors:

   1. Alireza Khani-Robati
   2. Mohammad Banizaman
   3. Farima Jahromi
   4. Maryam Porsadeghfard
   5. Elahe Rafiei
   6. Sachchida Nand Rai
   7. Amirhossein Yousefi Nejad
   8. Somayeh Akbari
   9. Maryam Naseh
   10. Mahnaz Bayat
   11. Mohammad Saied Salehi
   12. Masoud Haghani
   13. Bijan Akbarpour
   14. Etrat Hooshmandi